Search

CERN is getting ready to switch on its massive underground collider again. The Higgs boson, the standout discovery of the last few years, is in the bag, so what are physicists looking for now?

The President of Singapore today laid foundation stones to mark the development of two buildings for the Lee Kong Chian School of Medicine.

The MED-EU strategic project aims to raise EU funds for scientific research and innovation. The project is coordinated by the University of Bologna and a few clinical institutes such as the S.Orsola-Malpighi University Hospital, the Rizzoli Institute for Orthopedics and the Institute for Neurologic Sciences of the Bellaria hospital.

Breakthroughs in renewable energy don’t come from Eureka moments in the laboratory, but from long term effort and investment to push nascent technologies to the point of cost efficiency, says Carlos Härtel, GE’s head of R&D in Europe

Fluidic Analytics Limited, a spinout from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.

The Bloodhound car will be a 1,000mph machine that is part spaceship, part jet fighter and part racing car. This is not a big vanity project but an engineering adventure designed to stir a new generation, says Mark Elvin

Science|Business makes some guesses at what research and innovation topics are likely to be among the most discussed in 2015.

Allowing academics to move their pensions from country-to-country when taking up jobs at institutions across the EU has broad support. But there is a swathe of technical and legal detail to sort out and universities need to sign up

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Imperial has the greatest concentration of high impact research of any major UK university, according to the Research Excellence Framework (REF) 2014.

A total of 22 new companies were founded in 2014 by researchers from ETH Zurich. These spin-offs are among the most successful in Switzerland. One of the year's highlights was Covagen, which was acquired for over CHF 200 million. The latest figures also reveal that the university is on the right track with its promotion programmes.

Incessant talk of a North-South R&D divide is not baseless but it’s becoming tired. It is time to try and change things says Carlos Zorrinho, Brussels’ quiet revolutionary

Researchers at University of Bologna designed the first self-assembling molecular motor capable of converting light energy into work. The study was published in Nature Nanotechnology.

Three out of four Starting grants go to young researchers hosted by Germany, UK, France, the Netherlands, Israel and Spain. There are no grants going to Switzerland

Special emphasis was put on good usability in the selection process of the new research information management system.

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems.

For five years, robotics expert and Executive Board member Roland Siegwart has held the post of Vice President Research and Corporate Relations. He is now in the process of handing over this vice presidency to his successor, Detlef Günther, but he will always remain a firm fan of ETH Zurich.

Innovation clusters in life sciences and raw materials set to start in 2015, following year-long bidding competition

In the race to create world-beating technology companies from scratch, Germany spent most of the past thirty years on the sidelines. But the country’s start-up ecosystem is now flourishing - and foreign investors are taking a second look